The US stock exchanges have so far presented themselves on Tuesday without a common direction and quite volatile. After the strong start to the week, investors continued to pick up stocks, while tending to steer clear of technology stocks. US Federal Reserve Chairman Jerome Powell, meanwhile, advertised another economic stimulus on Tuesday and outlined the economic outlook as very uncertain.
The US leading index Dow Jones Industrial gained two hours before the market closed 0.33 percent to 28 241.62 points. For the market-wide S&P 500 it went up 0.18 percent to 3414.62 points. The tech-heavy Nasdaq 100
lost 0.36 percent to 11,468.03 points.
Investors shouldn’t dream of a year-end rally, wrote the chart technology experts from Index Radar with a view to the Dow. To do this, the index must first be bought sustainably above 28,200 points and then above 28,350 points, which from a technical point of view would send a positive signal.
The aircraft manufacturer Boeing expects due to the corona crisis in the next ten years with a significantly lower demand for new commercial aircraft. According to Boeing, demand will only recover in the ten years up to 2039. However, a full recovery will take years. Boeing shares lost 3.2 percent at the end of the Dow. The top stocks in the leading index were the stocks of the Wall Street bank Goldman Sachs
with an increase of two percent.
Pharmaceutical stocks made headlines again on Tuesday. So comes the Mainz company Biontech the possible market approval of its corona vaccine candidate one step closer: The European Medicines Agency Ema confirmed that the active ingredient BNT162b2 will be tested in the special procedure. Previously, Biontech and the pharmaceutical company Pfizer , who supports the development, announced the test procedure. Biontech shares, which are listed on the Nasdaq in New York, rose by around seven and a half percent, while Pfizer shares fell slightly./ajx/he
ISIN US2605661048 US6311011026 US78378X1072
AXC0413 2020-10-06/20:07
Copyright dpa-AFX Wirtschaftsnachrichten GmbH. All rights reserved. Redistribution, republication or permanent storage without the express prior consent of dpa-AFX is not permitted.
– .
